Quantcast

Latest Gynecologic Oncology Group Stories

2011-12-29 09:56:23

Targeted drugs, which block or disrupt particular molecules involved in the growth of tumors, have been shown to be effective treatments against many types of cancer. A new phase 3 clinical trial conducted by the Gynecologic Oncology Group (GOG) showed that a targeted therapy called bevacizumab (Avastin) effectively delayed the progression of advanced ovarian cancer. Patients with newly diagnosed advanced ovarian cancer now typically undergo surgery and chemotherapy, but the new research...

2011-05-03 09:00:00

Long-standing medical organization's name now reflects new membership base CHICAGO, May 3, 2011 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) has announced that it has revised its name to "The Society of Gynecologic Oncology." The name change, which was approved at the Society's 42nd Annual Meeting on Women's Cancer® this past March in Orlando, Florida, recognizes SGO's expanded membership which now includes representatives from the entire cancer...

2011-04-26 14:25:05

A clinical trial has sifted out the most effective single-drug chemotherapy regimen for quick-growing but highly curable cancers that arise from the placentas of pregnant women. In the comparison trial for treating low-risk gestational trophoblastic neoplasia (GTN), researchers found that a biweekly dose of dactinomycin had a higher complete response rate than a weekly dose of methotrexate, the more commonly used drug. GTN is a group of rare tumors that involve abnormal growth of cells inside...

2011-03-08 02:48:34

An analysis conducted by Ohio State University cancer researchers has found that adding the targeted therapy bevacizumab to the treatment of patients with advanced ovarian cancer is not cost effective. The findings comparing the relative value of various clinical strategies will be published online March 7 in the Journal of Clinical Oncology. The researchers performed a cost-effectiveness analysis looking at a clinical trial conducted by the Gynecologic Oncology Group (GOG) studying the use...

2011-02-28 11:00:00

Selected abstract points to efficacy of treatment guidelines and need for improved practices CHICAGO, Feb. 28, 2011 /PRNewswire-USNewswire/ -- In their continuing quest to eradicate women's cancers, gynecologic oncologists are developing new approaches to treatment, diagnosis and prevention of these diseases. An outstanding assortment of new research will be on display in Orlando, March 6 - 9, 2011, during the Society of Gynecologic Oncologists' (SGO) 42nd Annual Meeting on Women's Cancer,...

2011-02-11 22:07:30

A small proportion of adult cancer patients participate in clinical trials in part due to a low level of physician referrals, according to an online study published Feb. 11 in The Journal of the National Cancer Institute. Although more than 8000 clinical trials are accepting participants, according to the National Cancer Institute (NCI), only an estimated 2%ð”Æ’“š% of newly diagnosed cancer patients participate in them. Prior studies suggest that most...


Word of the Day
endocarp
  • The hard inner (usually woody) layer of the pericarp of some fruits (as peaches or plums or cherries or olives) that contains the seed.
This word comes from the Greek 'endon,' in, within, plus the Greek 'kardia,' heart.
Related